The risk for a first-time symptomatic kidney stone begins to increase in the second trimester and peaks 0 to 3 months after delivery, a study findings suggest.
Patient characteristics, such as dialysis use and diabetes status, appeared to be influential factors.
Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
Early detection of iron status may improve cardiovascular risk assessment in patients with CKD, according to investigators.
Bone loss in patients with kidney stone disease, particularly in men, has been underappreciated in clinical practice, according to investigators.
Nearly 80% of patients in a recent study had very low serum zinc values, which raises concern for the advanced CKD population at large, according to investigators.
Biopsy results support a SARS-CoV-2 kidney tropism in both proximal and distal tubules, according to the investigators, despite the absence of definitive ultrastructural evidence.
For patients with end-stage kidney disease, there has been little improvement in rates of waitlist placement or transplantation since 1997.
Social determinants of health and race are associated with the likelihood of undergoing a kidney transplant.
The effects of combined verinurad and febuxostat treatment were independent of blood pressure.
Study findings suggest NSAIDs may be a risk factor for acute kidney injury and hyperkalemia in patients with diabetes.
For patients with sickle cell disease, HSCT may not be associated with a significant increase in CKD incidence or prevalence following transplantation.
Patients older than 65 years whose salt intake is greater than 8 g/d have a nearly 44% decreased risk for end-stage kidney disease compared with those whose intake is less than 6 g/d, a study found.
Higher proportions of patients in the low to middle income brackets were diagnosed with localized renal cell carcinoma in states allowing Medicaid expansion.
Treatment with the sodium glucose cotransporter 2 (SGLT2) inhibitor canagliflozin can reduce rates of kidney disease progression.
A new decision support tool could optimize antibiotic prescribing for uncomplicated urinary tract infections in the outpatient setting.
Children hospitalized for chronic kidney disease may have a longer length of stay and increased cost compared with other illnesses.
The addition of belimumab vs placebo to standard therapy increases the likelihood of a primary efficacy renal response in patients with active lupus nephritis.
New study is the first focused analysis of bacterial diversity in the urogenital tract of postmenopausal women, according to investigators.
Practitioners who measure only urinary protein-to-creatinine ratio may be able to use a new albumin-to-creatinine ratio estimating equation to diagnose and manage kidney disease.